These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Adult ovarian granulosa cell tumor transcriptomics: prevalence of FOXL2 target genes misregulation gives insights into the pathogenic mechanism of the p.Cys134Trp somatic mutation. Benayoun BA; Anttonen M; L'Hôte D; Bailly-Bechet M; Andersson N; Heikinheimo M; Veitia RA Oncogene; 2013 May; 32(22):2739-46. PubMed ID: 22797072 [TBL] [Abstract][Full Text] [Related]
4. FOXO1 mitigates the SMAD3/FOXL2 Secchi C; Benaglio P; Mulas F; Belli M; Stupack D; Shimasaki S J Transl Med; 2021 Feb; 19(1):90. PubMed ID: 33639972 [TBL] [Abstract][Full Text] [Related]
5. The FOXL2 mutation (c.402C>G) in adult-type ovarian granulosa cell tumors of three Japanese patients: clinical report and review of the literature. Takahashi A; Kimura F; Yamanaka A; Takebayashi A; Kita N; Takahashi K; Murakami T Tohoku J Exp Med; 2013 Dec; 231(4):243-50. PubMed ID: 24257635 [TBL] [Abstract][Full Text] [Related]
6. The FOXL2 C134W mutation is characteristic of adult granulosa cell tumors of the ovary. Jamieson S; Butzow R; Andersson N; Alexiadis M; Unkila-Kallio L; Heikinheimo M; Fuller PJ; Anttonen M Mod Pathol; 2010 Nov; 23(11):1477-85. PubMed ID: 20693978 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of wild-type but not C134W mutant FOXL2 enhances GnRH-induced cell apoptosis by increasing GnRH receptor expression in human granulosa cell tumors. Cheng JC; Klausen C; Leung PC PLoS One; 2013; 8(1):e55099. PubMed ID: 23372819 [TBL] [Abstract][Full Text] [Related]
8. The transcriptional targets of mutant FOXL2 in granulosa cell tumours. Rosario R; Araki H; Print CG; Shelling AN PLoS One; 2012; 7(9):e46270. PubMed ID: 23029457 [TBL] [Abstract][Full Text] [Related]
9. A cellular model provides insights into the pathogenicity of the oncogenic FOXL2 somatic variant p.Cys134Trp. Herman L; Amo A; Legois B; Di Carlo C; Veitia RA; Todeschini AL Br J Cancer; 2024 May; 130(9):1453-1462. PubMed ID: 38429437 [TBL] [Abstract][Full Text] [Related]
10. Mutational analysis (c.402C>G) of the FOXL2 gene and immunohistochemical expression of the FOXL2 protein in testicular adult type granulosa cell tumors and incompletely differentiated sex cord stromal tumors. Hes O; Vaněček T; Petersson F; Grossmann P; Hora M; Perez Montiel DM; Steiner P; Dvořák M; Michal M Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):347-51. PubMed ID: 21293260 [TBL] [Abstract][Full Text] [Related]
11. Absence of a FOXL2 mutation (402C→G) in the blood of adult-type granulosa cell tumor patients possessing the FOXL2 mutation. Lee S; Kim TH; Won M; Ko JJ; Rho J; Lee K; Bae J Int J Gynecol Cancer; 2010 Nov; 20(8):1341-3. PubMed ID: 21051974 [TBL] [Abstract][Full Text] [Related]
12. Molecular pathogenesis in granulosa cell tumor is not only due to somatic FOXL2 mutation. Wang WC; Lai YC J Ovarian Res; 2014 Sep; 7():88. PubMed ID: 25297715 [TBL] [Abstract][Full Text] [Related]
13. Clinical and genetic analysis of recurrent adult-type granulosa cell tumor of the ovary: Persistent preservation of heterozygous c.402C>G FOXL2 mutation. Yanagida S; Anglesio MS; Nazeran TM; Lum A; Inoue M; Iida Y; Takano H; Nikaido T; Okamoto A; Huntsman DG PLoS One; 2017; 12(6):e0178989. PubMed ID: 28594898 [TBL] [Abstract][Full Text] [Related]
14. Differential apoptotic activities of wild-type FOXL2 and the adult-type granulosa cell tumor-associated mutant FOXL2 (C134W). Kim JH; Yoon S; Park M; Park HO; Ko JJ; Lee K; Bae J Oncogene; 2011 Apr; 30(14):1653-63. PubMed ID: 21119601 [TBL] [Abstract][Full Text] [Related]
15. FOXL2 molecular testing in ovarian neoplasms: diagnostic approach and procedural guidelines. Kommoss S; Anglesio MS; Mackenzie R; Yang W; Senz J; Ho J; Bell L; Lee S; Lorette J; Huntsman DG; Blake Gilks C Mod Pathol; 2013 Jun; 26(6):860-7. PubMed ID: 23348906 [TBL] [Abstract][Full Text] [Related]
16. The Oncogenic FOXL2 C134W Mutation Is a Key Driver of Granulosa Cell Tumors. Llano E; Todeschini AL; Felipe-Medina N; Corte-Torres MD; Condezo YB; Sanchez-Martin M; López-Tamargo S; Astudillo A; Puente XS; Pendas AM; Veitia RA Cancer Res; 2023 Jan; 83(2):239-250. PubMed ID: 36409821 [TBL] [Abstract][Full Text] [Related]
17. Aromatase is a direct target of FOXL2: C134W in granulosa cell tumors via a single highly conserved binding site in the ovarian specific promoter. Fleming NI; Knower KC; Lazarus KA; Fuller PJ; Simpson ER; Clyne CD PLoS One; 2010 Dec; 5(12):e14389. PubMed ID: 21188138 [TBL] [Abstract][Full Text] [Related]
18. Detection of FOXL2 C134W Mutation Status by a Novel BaseScope In Situ Hybridization Assay is Highly Sensitive and Specific for Adult Granulosa Cell Tumors. Hammer PM; Wang A; Beard C; Zdravkovic S; Tenney T; Liang B; Das I; Bremer R; Wang LC; McCluggage WG; Stewart CJR; Howitt BE Mod Pathol; 2023 Nov; 36(11):100318. PubMed ID: 37634867 [TBL] [Abstract][Full Text] [Related]
19. Novel FOXL2 Mutation in an Ovarian Adult Granulosa Cell Tumor: Report of a Case With Diagnostic and Clinicopathologic Implications. Nagy A; Niu N; Ratner E; Hui P; Buza N Int J Gynecol Pathol; 2024 Nov; 43(6):631-636. PubMed ID: 38426544 [TBL] [Abstract][Full Text] [Related]
20. A current perspective on the pathological assessment of FOXL2 in adult-type granulosa cell tumours of the ovary. Kommoss S; Gilks CB; Penzel R; Herpel E; Mackenzie R; Huntsman D; Schirmacher P; Anglesio M; Schmidt D; Kommoss F Histopathology; 2014 Feb; 64(3):380-8. PubMed ID: 24192202 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]